The National Comprehensive Cancer Network (NCCN) in the US has an expert panel which regularly updates its clinical and patient guidelines for Myeloproliferative Neoplasms (MPNs) – almost every year.
The 2026 physician guidelines were released earlier this year and the 2026 patient guidelines for MPNs have recently been released and are free to access.
